Filter News
Area of Research
- (-) Nuclear Science and Technology (4)
- Advanced Manufacturing (18)
- Biology and Environment (18)
- Building Technologies (1)
- Clean Energy (83)
- Computational Biology (1)
- Computational Engineering (1)
- Computer Science (3)
- Electricity and Smart Grid (1)
- Fusion and Fission (2)
- Fusion Energy (1)
- Isotopes (2)
- Materials (49)
- Materials for Computing (10)
- National Security (14)
- Neutron Science (12)
- Quantum information Science (2)
- Sensors and Controls (1)
- Supercomputing (25)
News Topics
- (-) 3-D Printing/Advanced Manufacturing (2)
- (-) Biomedical (2)
- Advanced Reactors (6)
- Bioenergy (1)
- Computer Science (1)
- Decarbonization (1)
- Fusion (2)
- Isotopes (3)
- Materials Science (1)
- Molten Salt (3)
- Neutron Science (3)
- Nuclear Energy (17)
- Physics (1)
- Space Exploration (4)
- Sustainable Energy (1)
- Transformational Challenge Reactor (1)
Media Contacts
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
Researchers at the Department of Energy’s Oak Ridge National Laboratory are refining their design of a 3D-printed nuclear reactor core, scaling up the additive manufacturing process necessary to build it, and developing methods
OAK RIDGE, Tenn., Feb. 19, 2020 — The U.S. Department of Energy’s Oak Ridge National Laboratory and the Tennessee Valley Authority have signed a memorandum of understanding to evaluate a new generation of flexible, cost-effective advanced nuclear reactors.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.